cris.boxmetadata.label.title
Factors associated to survival in patients with HIV-TB in the department of infectious diseases of the Arzobispo Loayza National Hospital, Perú, since 2004 to 2012
cris.boxmetadata.label.alternativetitle
Factores asociados a sobrevida en pacientes con co-infección VIH-TBC en el Servicio de Infectología del Hospital Nacional Arzobispo Loayza, Perú, durante los años 2004-2012.
cris.boxmetadata.label.dateissued
01 browse.startsWith.months.january 2018
cris.boxmetadata.label.accesslevel
open access
cris.boxmetadata.label.resourcetype
journal article
cris.boxmetadata.label.authors
Gamboa-Acuña B.
Guillén-Zambrano R.
Lizzetti-Mendoza G.
SOTO TARAZONA, ALONSO RICARDO
cris.boxmetadata.label.publisher
Sociedad Chilena de Infectologia
cris.boxmetadata.label.abstract
Background: The main cause of death in HIV patients is tuberculosis (TB). However, few Latin American studies have evaluated the prognosis of patients with coinfection. Aim: To determine the factors associated with survival in patients with HIV-TB coinfection treated at a Peruvian referral hospital. Methods: A retrospective cohort study was performed based on clinical records of patients treated at the Department of Infectious Diseases in the Arzobispo Loayza National Hospital from 2004 to 2012. Survival was assessed using the Kaplan-Meier estimator and Cox Proportional Hazard Model. Results: From 315 patients, 82 died during the follow-up. The mean of follow for each patient was 730 days. The multivariate analysis showed that receiving HAART (HR: 0,31; IC: 0,20-0,50; p < 0,01) and having more weight (HR: 0,96; IC 0,94–0,98; p < 0,01) when the coinfection was diagnosed, were protective factors; while having a pathology different from TB (HR: 1,88; IC: 1,19-2,98; p < 0,01), age in years (HR: 1,76; IC: 1,12-2,74; p ≤ 0,01) and being hospitalized when diagnosed with TB (HR: 1,69; IC 1,02-2,80; p < 0,04) were associated with lower survival. Discussion: Receiving HAART and having more weight when the coinfection is diagnosed were associated with a higher chance of survival.
cris.boxmetadata.label.citationstartpage
41
cris.boxmetadata.label.citationendpage
48
cris.boxmetadata.label.volume
35
cris.boxmetadata.label.issue
1
cris.boxmetadata.label.language
Spanish
cris.boxmetadata.label.ocdeknowledgeArea
Sistema respiratorio
cris.boxmetadata.label.subjects
cris.boxmetadata.label.doi
cris.boxmetadata.label.scopusidentifier
2-s2.0-85044722691
cris.boxmetadata.label.pubmedidentifier
cris.boxmetadata.label.source
Revista Chilena de Infectologia
cris.boxmetadata.label.containerissn
07161018
cris.boxmetadata.label.sourcefunding
Styrelsen för Internationellt Utvecklingssamarbete
cris.boxmetadata.label.sponsor
17. Rivero A, Federico P, Iribarren J, Caylá J, Miró J, Moreno S, et. al. Recomendaciones de GESIDA/Secretaría del Plan Nacional sobre el Sida para el tratamiento de la tuberculosis en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero de 2013). Enf infec Microbiol Clin 2013; 13: 672-84. Agradecimientos. A los miembros del Servicio de Infecto-logía del Hospital Nacional Arzobispo Loayza por brindarnos facilidades para la elaboración de esta investigación, y a nuestras familias, por ser el soporte durante estos años.
peru-layout.shadow-copies Directorio de Producción Científica Scopus